NOVO NORDISK

Live / Registered — Registered (as of 13 Apr 2021)

What this means for you

Registered since 13 Apr 2021. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79290058
Registration number
6317854
Mark type
Design + words
Filed
03 Apr 2020
Published for opposition
26 Jan 2021
Registered
13 Apr 2021
Attorney of record
Alexander Reid

Goods and services

  • Class 001 — Chemicals: Chemical preparations for use in industry; chemical additives for use in the manufacture of pharmaceuticals, cosmetics, hair lotions, disinfectants; chemical diagnostic reagents for industrial use, for non-medical and non-veterinary purposes; chemical preparations for use in the oil industry
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes and obesity; pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease; pharmaceutical preparations for hormone therapy and stem cells for medical purposes; drug delivery devices containing pharmaceutical preparations for haemostasis management, pharmaceutical preparations for the treatment of sickle cell disease, brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, pharmaceutical preparations for hormone therapy and stem cells for medical purposes; chemical preparations for use in medical devices, namely, drug delivery agents consisting of compounds that deliver a wide range of pharmaceuticals
  • Class 009 — Scientific and electric apparatus: downloadable electronic publications, namely, leaflets, books, booklets, handouts, magazines, as well as medical, instructional and teaching material in the field of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; downloadable electronic publications featuring electronic reports containing results from clinical trials and studies in the field of prevention and treatment of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; downloadable software applications for use with mobile devices for monitoring and management of medical data related to diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; computer hardware and downloadable software, for use with medical injection devices for collecting, transmitting, and displaying medical data; downloadable medical software for the management of medical data related to diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; downloadable software as a medical device, namely, software used in connection with medical devices to manage treatment of haemostasis management and for the treatment of sickle cell disease, brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cells for medical purposes
  • Class 010 — Medical apparatus: Medical and surgical apparatus and instruments, namely, hypodermic syringes and syringe pens; medical apparatus and instruments for reconstitution and injection of pharmaceutical preparations; medical apparatus and instruments, namely, injection devices for administration of pharmaceutical preparations, medical infusion pumps for delivering measured amounts of solutions into the bloodstream over time, infusion pump controllers, adhesive infusion devices for administering drugs; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; medical and surgical apparatus and instruments, namely, injection devices for the administration of pharmaceutical preparations and the wireless transmission of medical data in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; medical devices, namely, automatic needle insertion devices, protection caps for hypodermic syringes and medical pens; needles for injections; cartridges and carpules for administration of pharmaceutical preparations
  • Class 041 — Education and entertainment services: Educational services, namely, organizing and conducting educational programmes, coaching and training services for patients and healthcare professionals related to management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; arranging and conducting of educational conferences, congresses, seminars, symposiums and workshops related to the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment
  • Class 042 — Scientific and technological services: Providing scientific research information in the field of diabetes, obesity, haemostasis management, treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; providing temporary use of online non-downloadable software featuring technology that enables users to record, track, and generate reports regarding the condition, treatment and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment
  • Class 044 — Medical, beauty and agricultural services: Providing medical services via websites and mobile apps for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; providing medical information and medical counselling featuring the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment

Owner

Prosecution history

  • 15 Aug 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 27 Jul 2021 — FINAL DISPOSITION NOTICE SENT TO IB
  • 27 Jul 2021 — FINAL DISPOSITION PROCESSED
  • 13 Jul 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 13 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
  • 06 Feb 2021 — NOTIFICATION PROCESSED BY IB
  • 26 Jan 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 26 Jan 2021 — PUBLISHED FOR OPPOSITION
  • 13 Jan 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
  • 06 Jan 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
  • 06 Jan 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 17 Dec 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 17 Dec 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 17 Dec 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 17 Dec 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED

View this trademark record on Marksy